NOW FDA
APPROVED
SYMBRAVO
A powerful
new treatment
for when
migraine strikes
SYMBRAVO is an innovative treatment that was proven to provide rapid freedom from migraine pain and most bothersome symptoma at 2 hours and lasting pain freedom through 24 hours for some patients.
AVAILABLE IN THE COMING MONTHS
aMost bothersome symptom: nausea, light sensitivity, or sound sensitivity.
If you've struggled to get relief from migraine symptoms, talk to your doctor and find out how SYMBRAVO could be right for you.
In clinical studies, SYMBRAVO was shown to speed the absorption of its ingredients:
- Anti-inflammatory medicine, meloxicam
- Migraine medicine, rizatriptan
SYMBRAVO uses rapid absorption technology to speed the time it takes to get into the body. When taken at the onset of a migraine attack, it is thought to inhibit 2 key factors that contribute to migraine pain.
The exact way that SYMBRAVO works to treat migraine is unclear, and the clinical significance of the rapid absorption technology has not been established.
SYMBRAVO was proven effective, providing:
- Rapid freedom from migraine pain and freedom from most bothersome symptoma for some patients starting at 2 hours
- Long-lasting pain freedom through 24 hours for some patients
SYMBRAVO was shown to work in patients who have a history of insufficient response to their current migraine treatments. Proven effective during a migraine attack, SYMBRAVO can be taken early when pain is mild or later when pain is moderate or severe.
SYMBRAVO was generally well-tolerated
In clinical studies, 2% of patients experienced tiredness, and 2% experienced dizziness—the most common side effects. These are not all of the side effects of SYMBRAVO. Talk to your doctor about any side effects you may experience.
- a Most bothersome symptom: nausea, light sensitivity, or sound sensitivity.